CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-15 | Lemaitre Dan Director | Option exercise | +10,500 | $24.10 | $253K | 22,750 |
| 2023-05-15 | Lemaitre Dan Director | Option exercise | +14,000 | $25.52 | $357K | 36,750 |
| 2023-05-15 | Lemaitre Dan Director | Option exercise | +17,500 | $26.27 | $460K | 54,250 |
| 2023-05-15 | Lemaitre Dan Director | Sale | −43,450 | $56.98 | $2.5M | 10,800 |
| 2023-05-15 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −1,450 | 0 | ||
| 2023-05-15 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −10,500 | 0 | ||
| 2023-05-15 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −14,000 | 0 | ||
| 2023-05-15 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −17,500 | 0 | ||
| 2023-02-09 | Lemaitre Dan Director | Option exercise | +5,550 | $23.95 | $133K | 10,800 |
| 2023-02-09 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −5,550 | 1,450 | ||
| 2023-01-26 | ZARRILLI STEPHEN T Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Douglas Robert Andrew Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +30,000 | 30,000 | ||
| 2023-01-26 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2023-01-26 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +75,000 | 75,000 | ||
| 2023-01-26 | Scavilla Daniel T President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 |
Page 10 of 10 · 200 trades